Upgrade to SI Premium - Free Trial

Moderna (MRNA)

145.55 -3.32 (2.23%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Rothschild Redburn Downgrades Moderna (MRNA) to Sell September 3, 2026 2:31 AM - StreetInsider Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider Moderna to Present at Upcoming Conferences in September 2026 September 1, 2026 7:01 AM - StreetInsider BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast August 28, 2026 9:46 AM - StreetInsider Argus Upgrades Moderna (MRNA) to Buy August 28, 2026 7:19 AM - StreetInsider Moderna prices $2.6B convertible notes offering due 2032 August 28, 2026 7:00 AM - StreetInsider Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes August 28, 2026 7:00 AM - StreetInsider FDA approves Moderna's updated 2026-2027 COVID-19 vaccines August 27, 2026 3:58 PM - StreetInsider Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines August 27, 2026 3:58 PM - StreetInsider Moderna plans $2B convertible notes offering due 2032 August 27, 2026 7:21 AM - StreetInsider Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes August 27, 2026 7:21 AM - StreetInsider A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity August 26, 2026 9:20 AM - StreetInsider Wolfe Research Upgrades Moderna (MRNA) to Peerperform August 25, 2026 5:31 AM - StreetInsider Moderna (MRNA) PT Raised to $125 at Barclays August 25, 2026 4:08 AM - StreetInsider Active options: MRNA SOFI BABA INTC MARA META COIN AMD GOOGL MSFT WMT August 24, 2026 5:25 AM - StreetInsider Moderna (MRNA) call put ratio 1.1 calls to 1 put amid sharp rally August 24, 2026 5:21 AM - StreetInsider Moderna (MRNA) PT Raised to $77 at JPMorgan August 21, 2026 9:28 AM - StreetInsider BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough August 20, 2026 7:23 AM - StreetInsider Moderna stock pulls back after massive one-day rally: analysts weigh in August 20, 2026 7:23 AM - StreetInsider Moderna (MRNA) PT Raised to $150 at UBS August 20, 2026 6:55 AM - StreetInsider Guggenheim Reiterates Buy Rating on Merck (MRK) August 20, 2026 6:47 AM - StreetInsider Moderna (MRNA) PT Raised to $120 at Goldman Sachs August 20, 2026 6:43 AM - StreetInsider Moderna (MRNA) call put ratio 1 calls to 2.1 puts amid wide price movement August 20, 2026 4:51 AM - StreetInsider Moderna (MRNA) PT Raised to $89 at Morgan Stanley August 19, 2026 4:23 PM - StreetInsider Morgan Stanley Upgrades Merck (MRK) to Overweight August 19, 2026 4:22 PM - StreetInsider Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN August 19, 2026 3:11 PM - StreetInsider BofA Securities Upgrades Moderna (MRNA) to Neutral August 19, 2026 1:40 PM - StreetInsider Moderna short sellers face $4.8 billion loss amid record stock jump August 19, 2026 11:31 AM - StreetInsider Moderna (MRNA) call put ratio 1 calls to 1.9 puts after INTerpath-001 trial results August 19, 2026 11:21 AM - StreetInsider Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data August 19, 2026 9:34 AM - StreetInsider Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY August 19, 2026 9:18 AM - StreetInsider Moderna (MRNA) call put ratio 2.1 calls to 1 put into INTerpath-001 trial results August 19, 2026 9:11 AM - StreetInsider William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business August 19, 2026 8:11 AM - StreetInsider Moderna shares soar on melanoma drug trial success August 19, 2026 7:03 AM - StreetInsider Merck and Moderna's melanoma drug combo beats Keytruda alone in trial August 19, 2026 6:45 AM - StreetInsider Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients Wi August 19, 2026 6:45 AM - BizWire Form SCHEDULE 13G Moderna, Inc. Filed by: Capital World Investors August 12, 2026 5:41 PM - SEC Filing Form 4 Moderna, Inc. For: Aug 05 Filed by: Bancel Stephane August 7, 2026 4:12 PM - SEC Filing Trump Administration Weighs Order On Autism And Vaccines - Bloomberg August 6, 2026 4:36 PM - StreetInsider Form SCHEDULE 13G/A Moderna, Inc. Filed by: FMR LLC August 6, 2026 10:36 AM - SEC Filing Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine August 6, 2026 8:42 AM - StreetInsider FDA approves Moderna's mRNA influenza vaccine for adults 50 and older August 5, 2026 10:15 PM - StreetInsider Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA August 5, 2026 10:15 PM - StreetInsider Form 144 Moderna, Inc. Filed by: Bancel Stephane August 5, 2026 1:02 PM - SEC Filing Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine August 4, 2026 11:01 AM - StreetInsider Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus August 4, 2026 11:01 AM - StreetInsider Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) August 3, 2026 10:05 AM - StreetInsider U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage August 1, 2026 10:00 AM - StreetInsider Form 10-Q Moderna, Inc. For: Jun 30 July 31, 2026 4:18 PM - SEC Filing Form 8-K Moderna, Inc. For: Jul 31 July 31, 2026 7:04 AM - SEC Filing Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue July 31, 2026 7:01 AM - StreetInsider Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates July 31, 2026 7:01 AM - StreetInsider Form SCHEDULE 13G/A Moderna, Inc. Filed by: BAILLIE GIFFORD & CO July 24, 2026 10:11 AM - SEC Filing Moderna (MRNA) PT Raised to $67 at Goldman Sachs July 21, 2026 6:38 AM - StreetInsider Moderna (MRNA) PT Raised to $25 at Wolfe Research July 20, 2026 5:34 AM - StreetInsider Form 4 Moderna, Inc. For: Jul 15 Filed by: Hoge Stephen July 16, 2026 4:46 PM - SEC Filing Moderna doses first patient in Phase 1 trial for mRNA-4200 cancer therapy July 16, 2026 7:01 AM - StreetInsider Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors July 16, 2026 7:01 AM - StreetInsider Form 144 Moderna, Inc. Filed by: Hoge Stephen July 15, 2026 10:22 AM - SEC Filing Form 4 Moderna, Inc. For: Jul 08 Filed by: McDonnell Michael R. July 10, 2026 5:08 PM - SEC Filing Form 3 Moderna, Inc. For: Jul 08 Filed by: McDonnell Michael R. July 10, 2026 5:06 PM - SEC Filing JPMorgan analysts name top short ideas for third quarter 2026 July 10, 2026 11:12 AM - StreetInsider Moderna (MRNA) call put ratio 3.5 calls to 1 put with a focus on July 72 and 77 calls as share price down 9.5% July 10, 2026 10:42 AM - StreetInsider Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026 July 9, 2026 7:01 AM - StreetInsider Moderna (MRNA) PT Raised to $39 at Morgan Stanley July 8, 2026 8:08 AM - StreetInsider Form 8-K Moderna, Inc. For: Jul 06 July 8, 2026 7:08 AM - SEC Filing Moderna adds former Biogen CFO Michael McDonnell to its board July 8, 2026 7:01 AM - StreetInsider Moderna Appoints Michael McDonnell to Board of Directors July 8, 2026 7:01 AM - StreetInsider Form 4 Moderna, Inc. For: Jul 05 Filed by: Banque Soria Ester July 7, 2026 4:26 PM - SEC Filing Moderna (MRNA) PT Raised to $45 at RBC Capital July 7, 2026 7:59 AM - StreetInsider Moderna (MRNA) PT Raised to $38 at BofA Securities July 7, 2026 5:16 AM - StreetInsider Form 4 Moderna, Inc. For: Jul 02 Filed by: Mock James M July 6, 2026 4:31 PM - SEC Filing Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5% July 2, 2026 10:59 AM - StreetInsider Form 3 Moderna, Inc. For: Jun 15 Filed by: Banque Soria Ester June 30, 2026 4:34 PM - SEC Filing Moderna (MRNA) call put ratio 6.7 calls to 1 put with a focus on July 2 weekly 68 and 72 calls as share price up 11.5% June 26, 2026 10:42 AM - StreetInsider Moderna (MRNA) PT Raised to $77 at Piper Sandler June 26, 2026 9:25 AM - StreetInsider From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak June 26, 2026 7:02 AM - StreetInsider Moderna outlines three-horizon growth strategy at 2026 Science Day June 25, 2026 4:40 PM - StreetInsider Moderna outlines mRNA pipeline progress at Science Day event June 25, 2026 7:01 AM - StreetInsider Moderna Science Day Highlights Expanding Potential of mRNA Platform June 25, 2026 7:01 AM - StreetInsider FDA advisory panel votes 9-0 in favor of Moderna's mRNA flu vaccine June 18, 2026 4:00 PM - StreetInsider Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine June 18, 2026 4:00 PM - StreetInsider Form 144 Moderna, Inc. Filed by: SAGAN PAUL June 18, 2026 3:27 PM - SEC Filing Moderna Wins Fda Panel Backing For Mrna Flu Vaccine June 18, 2026 2:43 PM - StreetInsider Moderna's mRNA flu vaccine backed by FDA advisers June 18, 2026 6:02 AM - StreetInsider Form 4 Moderna, Inc. For: Jun 15 Filed by: Hoge Stephen June 17, 2026 4:11 PM - SEC Filing Moderna to Host Investor Event - Science Day June 17, 2026 7:01 AM - StreetInsider Moderna shares gain after FDA staff backs flu vaccine data June 16, 2026 1:50 PM - StreetInsider Moderna names new CCO and expands president's role ahead of product launches June 16, 2026 7:33 AM - StreetInsider Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028 June 16, 2026 7:31 AM - StreetInsider Form 144 Moderna, Inc. Filed by: Hoge Stephen June 15, 2026 11:43 AM - SEC Filing Moderna and Oxford receive UK authorization for Lynch syndrome cancer vaccine trial June 8, 2026 7:01 PM - StreetInsider Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome June 8, 2026 7:01 PM - StreetInsider Form 4 Moderna, Inc. For: Jun 04 Filed by: Klinger Shannon Thyme June 8, 2026 4:34 PM - SEC Filing Form 4 Moderna, Inc. For: Jun 05 Filed by: Mock James M June 8, 2026 4:31 PM - SEC Filing Full Article List